The New England Journal of Medicine (I love their studies) has published some extremely good news for Gilead's Remdesivir. Among the interesting results from the study is that the Chinese researchers lied. Remdesivir shortened a patient's time to recovery compared to the placebo group, from an average of 15 days to 11 days. Improvements occurred whether or not the patient was receiving supplemental oxygen. What's more, the data lays to rest any worries that remdesivir has to be given very early after the onset of symptoms. In fact, those participants who entered the trial more than 10 days after the onset of symptoms actually showed a better response to remdesivir than those who started being treated during the first 10 days!
No comments:
Post a Comment